BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11409565)

  • 1. Relationship between DNA ploidy-related parameters and the deletions in mismatch repair genes MLH1 and MSH2 in lentigo maligna and malignant melanomas.
    Korabiowska M; Viehöver M; Schlott T; Berger H; Droese M; Brinck U
    Arch Dermatol Res; 2001 May; 293(5):219-25. PubMed ID: 11409565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between DNA mismatch repair genes expression, Ku-genes expression and ploidy-related parameters in the progression of pigmented lesions of the skin.
    Korabiowska M; Tscherny M; Stachura J; Ruschenburg I; Cordon-Cardo C; Brinck U
    In Vivo; 2002; 16(5):317-21. PubMed ID: 12494870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exonic deletions of mismatch repair genes MLH1 and MSH2 correlate with prognosis and protein expression levels in malignant melanomas.
    Korabiowska M; Brinck U; Stachura J; Jawien J; Hasse FM; Cordon-Cardos C; Fischer G
    Anticancer Res; 2006; 26(2A):1231-5. PubMed ID: 16619529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of in situ hybridization probes for MLH-1 and MSH-2 in tissue microarrays of paraffin-embedded malignant melanomas: correlation with immunohistochemistry and tumor stage.
    Korabiowska M; Cordon-Cardo C; Jaenckel F; Stachura J; Fischer G; Brinck U
    Hum Pathol; 2004 Dec; 35(12):1543-8. PubMed ID: 15619215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes.
    Wang Y; Friedl W; Lamberti C; Jungck M; Mathiak M; Pagenstecher C; Propping P; Mangold E
    Int J Cancer; 2003 Feb; 103(5):636-41. PubMed ID: 12494471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the DNA mismatch repair proteins expression in malignant melanomas.
    Korabiowska M; Brinck U; Dengler H; Stachura J; Schauer A; Droese M
    Anticancer Res; 2000; 20(6B):4499-505. PubMed ID: 11205295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of DNA-mismatch repair gene expression in oral melanomas.
    Korabiowska M; Brinck U; Ruschenburg I; Honig JF; Stachura J; Droese M
    Oncol Rep; 1999; 6(4):921-3. PubMed ID: 10373682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer.
    Charbonnier F; Olschwang S; Wang Q; Boisson C; Martin C; Buisine MP; Puisieux A; Frebourg T
    Cancer Res; 2002 Feb; 62(3):848-53. PubMed ID: 11830542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between DNA ploidy status and the expression of the DNA-mismatch repair genes MLH1 and MSH2 in cytological specimens of melanoma lymph node and liver metastases.
    Korabiowska M; Ruschenburg I; Schlott T; Kubitz A; Brinck U; Droese M
    Diagn Cytopathol; 2001 Mar; 24(3):157-62. PubMed ID: 11241897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
    Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
    Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes.
    Lang J; MacKie RM
    J Invest Dermatol; 2005 Sep; 125(3):575-9. PubMed ID: 16117801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified multiplex PCR assay for detection of large deletions in MSH2 and MLH1.
    Wang Y; Friedl W; Sengteller M; Jungck M; Filges I; Propping P; Mangold E
    Hum Mutat; 2002 Mar; 19(3):279-86. PubMed ID: 11857745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Br J Cancer; 2005 Aug; 93(4):472-7. PubMed ID: 16106253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
    Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
    Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal and extracolonic cancer variations in MLH1/MSH2 hereditary nonpolyposis colorectal cancer kindreds and the general population.
    Lin KM; Shashidharan M; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lanspa SJ; Lemon SJ; Watson P; Lynch HT
    Dis Colon Rectum; 1998 Apr; 41(4):428-33. PubMed ID: 9559626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach.
    Gille JJ; Hogervorst FB; Pals G; Wijnen JT; van Schooten RJ; Dommering CJ; Meijer GA; Craanen ME; Nederlof PM; de Jong D; McElgunn CJ; Schouten JP; Menko FH
    Br J Cancer; 2002 Oct; 87(8):892-7. PubMed ID: 12373605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families.
    Vasen HF; Stormorken A; Menko FH; Nagengast FM; Kleibeuker JH; Griffioen G; Taal BG; Moller P; Wijnen JT
    J Clin Oncol; 2001 Oct; 19(20):4074-80. PubMed ID: 11600610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA.
    Taylor CF; Charlton RS; Burn J; Sheridan E; Taylor GR
    Hum Mutat; 2003 Dec; 22(6):428-33. PubMed ID: 14635101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.